J. Scott Wolchko, President and CEO at FATE THERAPEUTICS INC (FATE), sold 50,000 shares at $38.02 ($2.0M) on 2022-01-21, disclosed to the SEC on 2022-01-24.
Seasonal sale ($2.0M) by President and CEO — this insider has traded FATE in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.21 | 30,000 | $1.2M | 61.3% |
| 2 | $38.02 | 10,000 | $380K | 19.3% |
| 3 | $38.02 | 10,000 | $380K | 19.3% |
| Total | $39.33 avg | 50,000 | $2.0M | 100% |
| Filing → |
| FATE | SELL | 2022-07-25 | $2.4M | — | Filing → |
| FATE | SELL | 2022-04-25 | $2.6M | — | Filing → |
| FATE | SELL | 2022-01-13 | $1.4M | — | Filing → |